Role of serotonin in emesis

Folia Pharmacologica Japonica

Volumn 108, Issue 5, 1996, Pages 233-242

  Minami, Masaru ^a   Endo, Toru ^a   Hirafuji, Masahiko ^a  

^a HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYL 3 INDAZOLECARBOXYLIC ACID N TROPANYLAMIDE; 2,3 DIHYDRO 2 OXO 1 BENZIMIDAZOLECARBOXYLIC ACID 6 METHOXY 3ALPHA TROPANYL ESTER; 3 (2 METHOXYBENZYLAMINO) 2 PHENYLPIPERIDINE; 3 (5 METHYL 1H IMIDAZOL 4 YL) 1 (1 METHYL 1H INDOL 3 YL) 1 PROPANONE; 4 AMINO 5 CHLORO 2 METHOXYBENZOIC ACID 2 (DIETHYLAMINO)ETHYL ESTER; 4 AMINO 5 CHLORO N (8 METHYL 8 AZABICYCLO[3.2.1]OCT 3ALPHA YL) 2 (1 METHYL 2 BUTYNYLOXY)BENZAMIDE; 5 METHOXYTRYPTAMINE; 8 AMINO 7 CHLORO 1,4 BENZODIOXAN 5 CARBOXYLIC ACID 1 BUTYL 4 PIPERIDINYLMETHYL ESTER; AS 5370; AZASETRON; BATANOPRIDE; BUSPIRONE; CISAPRIDE; CISPLATIN; DAZOPRIDE; DOMPERIDONE; DOPAMINE 2 RECEPTOR BLOCKING AGENT; FABESETRON; GRANISETRON; INDISETRON; ITASETRON; LY 2288729; METOCLOPRAMIDE; MUSCARINIC RECEPTOR BLOCKING AGENT; RENZAPRIDE; RICASETRON; SCOPOLAMINE; SEROTONIN 3 RECEPTOR; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; TACHYKININ RECEPTOR ANTAGONIST; TROPISETRON; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZAMIFENACIN;

CONCENTRATION RESPONSE; ELECTROSTIMULATION; HUMAN; INTESTINE MUCOSA; MEMBRANE DEPOLARIZATION; RECEPTOR BINDING; REVIEW; SEROTONIN RELEASE; VAGOTOMY; VOMITING;

EID: 0029977909     PISSN: 00155691     EISSN: None     Source Type: Journal    
DOI: 10.1254/fpj.108.233     Document Type: Review

References (50)

1. Fukuda H and Koga T: The Botzinger complex as the pattern generator for retching and vomiting in the dog. Neurosci Res 12, 471-485 (1991)
2. Wang SC and Borison HL: A new concept of organization of the central emetic mechanism: recent studies on the sites of action of apomorphine, copper sulfate and cardiac glycosides. Gastroenterology 22, 1-2 (1952)
3. Bradley PB, Engel G, Feniuk W, Fozard JR, Humphrey PPA, Middlemiss DN, Mylecharane EJ, Richardson BP and Saxena PR: Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology 25, 563-576 (1986)
4. Miner WD and Sanger GJ: Inhibition of cisplatin-induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism. Br J Pharmacol 88, 497-499 (1986)
5. Erspamer VAD and Testinini A: Observations on the release and turnover rate of 5-hydroxytryptamine in the gastrointestinal tract. J Pharm Pharmacol 11, 618-623 (1959)
6. Nillson O, Ericson LE, Dahlstrom A, Ekholm R, Steinbusch HWM and Ahiman H: Subcelluar localization of serotonin immunoreactivity in rat enterochromaffin cells. Histochem 82, 351-355 (1985)
7. Racké K and Schwȯrer H: Regulation of serotonin release from the intestinal mucosa. Pharmacol Res 23, 13-25 (1991)
8. 4 receptors affects the release of 5-hydroxytryptamine from the ferret and rat intestine. Res Commun Mol Pathol Pharmacol 89, 131-142 (1995)
9. Endo T, Takahashi M, Minami M, Monma Y, Yoshioka M, Saito H and Parvez H: Effects of anticancer drugs on enzyme activities and serotonin release from ileal tissue in ferrets. Biogenic Amines 9, 479-489 (1993)
10. Endo T, Minami M, Monma Y, Yoshioka M, Saito H, Kinami J, Toshimitsu Y and Parvez H: Effect of GR38032F on cisplatin- and cyclophosphamide-induced emesis in the ferret. Biogenic Amines 7, 525-533 (1990)
11. 3 antagonist, on copper sulfate-induced emesis in the ferret. Biogenic Amines 8, 79-86 (1991)
12. Andrews PLR, Rapeport WG and Sanger GL: Neuropharmacology of emesis induced by anticancer therapy. Trends Pharmacol Sci 9, 334-341 (1988)
13. Thomas DP and Vane JR: 5-Hydroxytryptamine in the circulation of the dog. Nature 216, 335-336 (1967)
14. Yoshioka M, Kikuchi A, Matsumoto M, Ushiki T, Minami M and Saito H: Evaluation of 5-hydroxytryptamine concentration in portal vein measured by microdialysis. Res Commun Chem Pathol Pharmacol 79, 370-376 (1992)
15. Murphy TM, Munoz NM, Moss J, Blake JS, Mack MM and Leff AR: PAF-induced contraction of canine trachea mediated by 5-hydroxytryptamine in vivo. J Appl Physiol 66, 638-643 (1989)
16. Cubeddu LX, Hoffman IS, Fleunmayor NT and Malave JJ: Changes in serotonin metabolism in cancer patients: its relationship to nausea and vomiting induced by chemotherapeutic drugs. Br J Cancer 66, 198-203 (1992)
17. 4 receptors of the release of 5-hydroxytryptamine from the guinea-pig small intestine. Naunyn Schmiedebergs Arch Pharmacol 347, 137-140 (1993)
18. Cubeddu LX, Hoffman IS, Fleunmayor NT and Finn AL: Efficacy of ondansetron and the role of serotonin in cisplatin-induced nausea and vomiting. N Engl J Med 322, 810-816 (1990)
19. Bargsten G and Grube D: Serotonin storage and chromogranins: an experimental study in rat gastric endocrine cells. J Histochem Cytochem 40, 1147-1155 (1992)
20. Minami M, Endo T, Monma Y and Shiroshita Y: Pharmacology of emesis induced by anticancer drugs. J Toxicol Sci 16, Supp II, 35-39 (1991)
21. Torii Y, Mutoh M, Saito H and Matsuki N: Involvement of free radicals in cisplatin-induced emesis in suncus murinus. Eur J Pharmacol 248, 131-135 (1993)
22. Leslie RA: Neuroactive substances in the dorsal vagal complex of the medulla oblongata: Nucleus of the tractus solitarius, area postrema, and dorsa motor nucleus of the vagus. Neurochem Int 7, 191-211 (1985)
23. 3 antagonist) inhibited the increase of serotonin concentration induced by cytotoxic drugs in the area postrema of ferrets. Biogenic Amines 9, 163-175 (1992)
24. Minami M, Saito H and Yoshioka M: Toxicological aspects of cisplatin-induced emesis with emphasis on serotonin release. J Toxicol Sci 20 (app), 77-85 (1995)
25. Grundy D: Vagal control of gastrointestinal function. Baillieres Clin Gastroenterol 2, 23-43 (1988)
26. Carpenter DO, Briggs DB and Strominger N: Responses of neurons of canine area postrema to neurotransmitters and peptides. Cell Mol Neurobiol 3, 113-126 (1983)
27. Endo T, Nemoto M, Minami M, Yoshioka M, Saito H and Parvez SH: Changes in the afferent abdominal vagal nerve activity induced by cisplatin and copper sulfate in the ferret. Biogenic Amines 11, 399-407 (1995)
28. Minami M, Endo T, Nemoto M, Hamaue N, Hirafuji M, Monma Y, Yajima T, Yoshioka M and Saito H: How do toxic emetic stimuli cause serotonin release in the gut and the brain? In Serotonin and the Scientific Basis of Anti-emetic Therapy, Edited by Reynolds DJM, Andrews PLR and Davis CJ, pp68-76, Oxford Clinical Communications, Oxford (1995)
29. Newson B, Ahlman H, Dahlstrom A and Nyhus LM: Ultrastructural observations in the rat ileal mucosa of possible epithelial "taste cells" and submucosal sensory neurons. Acta Physiol Scand 114, 161-164 (1982)
30. 3 receptor in the anesthetized ferret. J Physiol (Lond) 422, 92p (1990)
31. Andrews PLR and Bhanfari P: Resinferatoxin, an ultrapotent capsaicin analogue, has anti-emetic properties in the ferret. Neuropharmacology 32, 799-806 (1993)
32. Round A and Wallis DI: The depolarizing action of 5-hydroxytryptamine on rabbit vagal afferent and sympathetic neurons in vitro and is selective blockade by ICS205-930. Br J Pharmacol 88, 485-494 (1986)
33. Higashi H and Nishi S: 5-Hydroxytryptamine receptors of visceral primary afferent neurons on rabbit nodosa ganglia. J Physiol (Lond) 323, 543-567 (1982)
34. Yoshioka M, Ikeda T, Abe M, Togashi H, Minami M and Saito H: Pharmacological characterization of 5-hydroxytryptamine-induced excitation of afferent cervical vagus nerve in anaesthetized rats. Br J Pharmacol 106, 544-549 (1992)
35. Hartig PR: The molecular biology of 5-HT receptors. Trends Pharmacol Sci 10, 64-69 (1989)
36. Wallis DI: Interaction of 5-hydroxytryptamine with autonomic and sensory neurons. In The Peripheral Actions of 5-Hydroxytryptamine, Edited by Fozard JR, pp220-246, Oxford University Press, Oxford (1989)
37. 3 receptors in three isolated preparations derived from guinea-pig tissues. Br J Pharmacol 101, 591-598 (1990)
38. 4 receptors in copper sulfate-induced vomiting in dogs. Eur J Pharmacol 257, 47-52 (1994)
39. 4 receptor antagonists and their potential therapeutic utility. Drugs Future 19, 1109-1121 (1995)
40. 4 receptors. Eur J Pharmacol 271, 159-166 (1994)
41. Lucot JB and Crampton GH: 8-OH-DPAT suppresses vomiting in the cat elicited by motion, cisplatin or xylazine. Pharmacol Biochem Behav 33, 627-631 (1989)
42. 1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis. Br J Pharmacol 96, 283-290 (1989)
43. Reiman A and Racké K: Stimulus-dependent inhibition by octreotide of 5-HT release from isolated small intestine. Gastroenterology 32, Supp 2, 82-85 (1994)
44. Satoh Y, Habara Y, Ono K and Kanno T: Carbamylcholine- and catecholamine-induced intracellular calcium dynamics of epithelial cells in mouse ileal crypts. Gastroenterology 108, 1345-1356 (1995)
45. 4 receptors in guinea pig ileum. Br J Pharmacol 111, 419-424 (1994)
46. 1 receptor in emetic responses: the anti-emetic effects of CP-99,994 in the ferret and dog. Br. J Pharmacol 115, 84-94 (1995)
47. Costello DJ and Borison HL: Naloxone antagonizes narcotic selfblockade of emesis in the cat. J Pharmacol Exp Ther 203, 222-230 (1977)
48. Andrews PLR: Physiology of nausea and vomiting. Br J Anaesth 69, 2s-19s (1992)
49. Carr DB, Bergland R, Hamilton A, Blume H, Kasting N, Arnold M, Martin JB and Rosenblatt M: Endotoxin-stimulated opioid peptide secretion: Two secretory pools and feedback control in vivo. Science 217, 845-848 (1982)
50. Stott JRR and Golding JF: The effect of a selective muscarinic receptor antagonist and scopolamine on motion sickness, skin conductance and heart rate in humans. J Physiol (Lond) 476, 47p (1994)